We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

71 hedge funds and large institutions have $173M invested in Apollo Endosurgery, Inc. in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $607K | Put options by funds: $198K

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 23

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

1% less funds holding

Funds holding: 7271 (-1)

28% less capital invested

Capital invested by funds: $239M → $173M (-$66.1M)

Holders
71
Holders Change
-1
Holders Change %
-1.39%
% of All Funds
1.12%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
13
Increased
23
Reduced
23
Closed
14
Calls
$607K
Puts
$198K
Net Calls
+$409K
Net Calls Change
-$554K

APEN Hedge Fund Activity: Q1 2022 in Review

71 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2022, worth a combined $173M — down 28% from $239M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of APEN and 13 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 23 added.

The largest buyer was Citigroup, adding an estimated $6.72M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $3.51M sold.

  • 71 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2022, down from 72 in Q4 2021.
  • Funds reported $173M of Apollo Endosurgery, Inc. stock for Q1 2022, down 28% quarter-over-quarter.
  • 13 funds opened new Apollo Endosurgery, Inc. positions in Q1 2022 and 14 closed out, a net change of -1 holder.
  • The largest Apollo Endosurgery, Inc. buyer in Q1 2022 was Citigroup, an estimated $6.72M added.
  • The largest Apollo Endosurgery, Inc. seller in Q1 2022 was Adage Capital Partners, an estimated $3.51M sold.

Based on aggregated 13F filings for Q1 2022.